14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 INVA stock ended at $15.45. This is 1.64% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 3.22% from a day low at $15.07 to a day high of $15.56.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Innoviva, Inc prices

Date Open High Low Close Volume
May 06, 2024 $15.12 $15.56 $15.07 $15.45 351 624
May 03, 2024 $15.53 $15.63 $15.13 $15.20 411 643
May 02, 2024 $15.24 $15.37 $15.09 $15.37 387 595
May 01, 2024 $15.18 $15.34 $15.01 $15.23 348 613
Apr 30, 2024 $15.53 $15.53 $14.95 $15.11 561 659
Apr 29, 2024 $15.23 $15.60 $15.12 $15.54 516 417
Apr 26, 2024 $15.01 $15.29 $15.01 $15.26 279 142
Apr 25, 2024 $15.08 $15.08 $14.90 $14.99 487 858
Apr 24, 2024 $15.18 $15.30 $15.05 $15.16 391 871
Apr 23, 2024 $14.95 $15.35 $14.89 $15.17 1 475 016
Apr 22, 2024 $14.98 $15.16 $14.83 $14.93 776 389
Apr 19, 2024 $14.69 $15.02 $14.69 $14.95 635 949
Apr 18, 2024 $14.49 $14.71 $14.44 $14.69 636 366
Apr 17, 2024 $14.48 $14.63 $14.35 $14.48 502 319
Apr 16, 2024 $14.40 $14.55 $14.33 $14.47 478 961
Apr 15, 2024 $14.58 $14.66 $14.36 $14.40 519 830
Apr 12, 2024 $14.68 $14.68 $14.49 $14.63 425 947
Apr 11, 2024 $14.66 $14.74 $14.53 $14.71 323 343
Apr 10, 2024 $14.51 $14.71 $14.47 $14.60 641 740
Apr 09, 2024 $14.76 $14.88 $14.68 $14.72 331 397
Apr 08, 2024 $14.69 $14.77 $14.59 $14.73 329 686
Apr 05, 2024 $14.62 $14.74 $14.51 $14.66 852 088
Apr 04, 2024 $14.93 $14.97 $14.57 $14.66 522 908
Apr 03, 2024 $14.74 $14.82 $14.33 $14.81 1 219 286
Apr 02, 2024 $15.16 $15.24 $14.76 $14.80 709 097
Click to get the best stock tips daily for free!

About Innoviva, Inc

Innoviva Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY... INVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT